Stage 2: 256 Real Stories

256 stories match stage 2. 227 of them mention surgery.

Shannon, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II MSI-High Colorectal Cancer: Shannon's Survivor Story

Patient Info: Shannon, Female, Under 40 | Stage II

Biomarkers: MSI-H; Lynch syndrome; MLH1 mutation

As of October 2023, Shannon had no recurrence described while approaching year 5 after Stage IIA colon cancer surgery and continued intensive Lynch syndrome surveillance.

The Patient Story
OutcomeCancer-Free / NED
Megan, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II HR-Positive Invasive Lobular Carcinoma: Megan's Survivor Story

Patient Info: Megan Claire Chase, Female | Stage II

Biomarkers: ER-positive; PR-positive; HER2 not reported

As of July 2023, Megan-Claire was in survivorship after Stage II invasive lobular breast cancer, with clear early scans but significant long-term effects, surgical menopause, chronic pain, fatigue, chemo brain, and inability to tolerate recurrence-prevention medications.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Megan-Claire, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II Invasive Lobular Carcinoma: Megan-Claire's Survivor Story

Patient Info: Megan-Claire, Female, Under 40 | Stage II

As of July 2023, Megan-Claire had completed chemotherapy, breast-conserving surgery with reconstruction/reduction, and 33 radiation rounds, and was living with long-term effects including neuropathy, scarring, fatigue, and radiation trauma; no recurrence or NED status was stated.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Cynthia, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II Invasive Ductal Carcinoma: Cynthia's Survivor Story

Patient Info: Cynthia, Female | Stage II

As of June 2023, Cynthia described herself as cancer-free and about 4 years out from treatment, while continuing normal follow-up and managing survivorship effects including nerve pain, stiffness, and severe fragrance-related skin allergy after radiation.

The Patient Story
OutcomeCancer-Free / NED
Cynthia, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Cynthia: Stage II Breast Cancer

Patient Info: Cynthia, Female | Stage II

Cynthia completed surgery and 25 rounds of radiation for Stage IIB invasive ductal carcinoma and was about 4 years into survivorship with normal follow-up, ongoing physical effects, and breast cancer education advocacy.

The Patient Story
OutcomeSurvivorship / Surveillance
Wendy, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Wendy's Survivor Story

Patient Info: Wendy Tamis Robbins, 50s | Stage II

Wendy was cancer-free and in surveillance with regular scans and check-ups after surgery and chemotherapy.

Dana-Farber
OutcomeCancer-Free / NED
Stephanie, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Stephanie's Survivor Story

Patient Info: Stephanie Tufano, Female, Under 40 | Stage II

As of June 2023, Stephanie had Stage II colon cancer removed surgically, received a clean bill of health, did not need chemotherapy or further treatment, and returned to running, coaching and family life.

Cleveland Clinic
OutcomeCancer-Free / NED
Christine, who was diagnosed with Stage II Lung CancerLung Cancer

Stage II HR-Positive Lung Cancer: Christine's Survivor Story

Patient Info: Christine, Female | Stage II

Biomarkers: Lung cancer biomarkers not reported; prior breast cancer described as ER-positive, PR-positive, HER2-positive / triple-positive

Reached complete remission from both Stage III triple-positive breast cancer and a separate Stage IIA primary lung cancer after about 1 year, including breast cancer chemotherapy/radiation and lower lung resection.

The Patient Story
OutcomeCancer-Free / NED
Christine, who was diagnosed with Stage II Lung CancerLung Cancer

Stage II Lung Cancer: Christine's Patient Story

Patient Info: Christine, Female, Under 40 | Stage II

As of May 2023, Christine’s lung-cancer story focused on diagnosis of an unexpected Stage IIA lung tumor during breast cancer treatment and the importance of pushing for biopsy when the finding was initially downplayed.

The Patient Story
OutcomeCare Ongoing
Amanda, who was diagnosed with Stage II Colorectal CancerColorectal Cancer

Stage II Colorectal Cancer: Amanda's Survivor Story

Patient Info: Amanda, Female, Under 40 | Stage II

Biomarkers: Genetic mutations involving colon, kidney, and skin cancer risk were reported; specific genes were not named

As of May 2023, Amanda had completed surgery and chemotherapy for Stage IIA sigmoid colon cancer and was in close surveillance, with CT scans every 6 months, bloodwork every 3 months, colonoscopy follow-up, and normal cancer-marker bloodwork.

The Patient Story
OutcomeSurvivorship / Completed Treatment
Tara, who was diagnosed with Stage II Invasive Lobular CarcinomaBreast Cancer

Stage II Invasive Lobular Carcinoma: Tara's Survivor Story

Patient Info: Tara, Female, 50s | Stage II

Biomarkers: Estrogen-based breast cancer

As of April 2023, Tara was in survivorship after bilateral mastectomy with tissue expanders for Stage II ILC, with clear margins, clear lymph nodes, right-breast LCIS, and no chemotherapy because of cardiac risk.

Lobular Breast Cancer Alliance
OutcomeSurvivorship / Completed Treatment
A patient, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

HER2-positive breast cancer on hemodialysis: partial response to T-DM1 then no metabolically active disease

Patient Info: Anonymized, Female, 60s | Stage II

Biomarkers: Hormone receptor-positive; HER2/neu-positive; E-cadherin-positive; Ki-67 55-60%; luminal B type

As of March 2023, after 12 total cycles of T-DM1 and modified radical mastectomy, PET-CT showed no metabolically active disease, and she continued endocrine therapy and dialysis.

PubMed Central
OutcomeCancer-Free / NED
Renée, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Renée's Patient Story

Patient Info: Renée, Female, Under 40 | Stage II

Biomarkers: Not genetically inherited; breast cancer linked by her team to prior doxorubicin exposure and total-body radiation

As of February 2023, Renée described stable health, working treatments, good bloodwork, and ongoing long-term hormone/anti-cancer therapy; she did not consider herself cancer-free and preferred survivor/thriver language.

The Patient Story
OutcomeCare Ongoing
Lucy, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Triple-Negative Breast Cancer: Lucy's Patient Story

Patient Info: Lucy, Female, Under 40 | Stage II

Biomarkers: BRCA1 mutation; triple-negative breast cancer

As of January 2023, Lucy had gone through fertility preservation, chemotherapy, and double mastectomy for Stage II grade 3 triple-negative breast cancer with BRCA1 mutation; no NED or recurrence status was stated.

The Patient Story
OutcomeCare Ongoing
Lanie, who was diagnosed with Stage II Invasive Ductal CarcinomaBreast Cancer

Stage II HER2-Positive Invasive Ductal Carcinoma: Lanie's Patient Story

Patient Info: Lanie Jones, Female, Under 40 | Stage II

Biomarkers: HER2-positive; Li-Fraumeni syndrome / TP53 mutation; BRCA-negative

As of January 2023, Lanie was living with Li-Fraumeni syndrome after 5 cancer diagnoses and was on lifelong maintenance chemotherapy while advocating for genetic testing and specialized surveillance.

The Patient Story
OutcomeCare Ongoing
Angelina, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Angelina's Patient Story

Patient Info: Angelina, Female, 50s | Stage II

As of 2023, Angelina was undergoing Stage II breast cancer treatment with DIEP mastectomy, chemotherapy, radiation therapy, and hormone therapy, and was focused on recuperation and future goals.

Our Cancer Stories
OutcomeCare Ongoing
Maiv, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Maiv's Patient Story

Patient Info: Maiv | Stage II

Maiv had completed active treatment and remained on hormone therapy at the time of her story.

Our Cancer Stories
OutcomeCare Ongoing
Anne, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Anne's Patient Story

Patient Info: Anne, Female, 50s | Stage II

As of 2023, Anne was receiving/continuing care for Stage II breast cancer after lumpectomy, paclitaxel chemotherapy, radiation therapy, and a targeted-therapy plan reduced to 9 rounds by insurance coverage.

Our Cancer Stories
OutcomeCare Ongoing
Amanda, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Amanda's Survivor Story

Patient Info: Amanda, Female, 70+ | Stage II

Amanda completed breast-conserving surgery, lymph-node surgery, chemotherapy and radiation. She entered survivorship and focused on living one day at a time rather than using a specific remission label.

Our Cancer Stories
OutcomeTreatment Completed / Survivorship
Annie, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Annie's Patient Story

Patient Info: Annie, Female, 40s | Stage II

As of 2023, Annie was still receiving care for Stage II breast cancer after completing chemotherapy and hormonal therapy, with lumpectomy, lymphadenectomy, radiation therapy, and immunotherapy still ahead in her plan.

Our Cancer Stories
OutcomeCare Ongoing
Margaret, who was diagnosed with Stage II Breast CancerBreast Cancer

Stage II Breast Cancer: Margaret's Patient Story

Patient Info: Margaret | Stage II

Margaret chose mastectomy and hormone therapy and reported no treatment side effects while remaining optimistic about recovery.

Our Cancer Stories
OutcomeNot reported